Author: Hanson, R.N.

Source: Current Pharmaceutical Design, Volume 6, Number 14, 1 September 2000 , pp. 1457-1468(12)

Publisher: Bentham Science Publishers

Abstract:

Targeted radiotherapy using Auger electron-emitting pharmaceuticals offers both advantages and challenges compared to alternative alpha - or beta -emitting agents. The low energy Auger electrons deposit their energy within the target cell thereby minimizing collateral damage. To achieve this effect, however, the radiopharmaceutical must incorporate the appropriate radionuclide, be efficiently synthesized, and once administered, be distributed selectively to its biological target. This review covers the synthesis of agents which have prepared over the past decade either as Auger electron-emitting radiopharmaceuticals or which have the potential as such. While not an exhaustive review, the major classes of agents, such as hormone receptor ligands, nucleoside analogs and intercalating agents are described.

Keywords: Synthesis; Auger Electron emitting Radiopharmaceuticals; Targeted radiotherapy; Hormone receptor ligands; Nucleoside analogs; Intercalating agents; Chromium 51; Gallium 67; Bromine 77, 80m; Indium 111; Iodine 123, 125; Platinum 193m; Thallium 201; Hormone receptor ligands; Nuclear Receptor Binding; DNA directed agents; Estrogen receptor ligands; Radiodiagnostic PET and SPECT; Flutamide; Anandron; Bicalutamide; Iodo bicalutamide; DNA directed agents; Radioiodinated oligonucleotides

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1381612003399211

Publication date: 2000-09-01

More about this publication?

• Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
  
  Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Hanson, R.N.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers